The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...

Enzymes, the core catalysts in life, drive critical biological processes ranging from metabolic regulation to energy ...

Monoclonal antibodies lead biosimilar approvals because of their large market size, well-defined regulatory pathways, and ...

In 2021, the 30.7 million beneficiaries accounted for over $2 billion in payments for the 101 generic drugs. Under the ...